CClinicalTrials.gg
CompletedNCT00900601Updated May 29, 2018Results posted

Surgical Treatment of Pelvic Joint Instability in Patients With Severe Pelvic Girdle Pain After Pregnancy and Trauma

An interventional study of Arthrodesis to the sacroiliac joint and symphysis in Pelvic Joint Instability and Pelvic Pain, sponsored by Oslo University Hospital. Completed at 1 site in Norway. Per ClinicalTrials.gov, last updated 2018-05-29.

Sponsored by Oslo University Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
9
Allocation
Not applicable
Sex
All
01

Study summary

Pelvic girdle pain (PGP) related to pregnancy is a common reason to sick leave during pregnancy. Low back pain and PGP affects about 50% of women during pregnancy. Most of the women recover, however about 10% of the women still have complaints after birth. Most patients have positive effect from conservative treatment, but unfortunately some do still have much pain despite intensive conservative rehabilitation. Surgery has been tried on these women with various results. Surgical treatment is controversial and there is a lack of documentation. The investigators will operate 20 patients with arthrodesis to the sacroiliac joint and symphysis. Radiostereometric analysis (RSA) will be used to evaluate the joint movement in different part of the process.

Hypothesis: Severe pelvic girdle pain is caused by pelvic joint instability in some cases and surgically fixation of the affected joints can help these women to get back to a normal life.

02

Conditions studied

  • Pelvic Joint Instability
  • Pelvic Pain

Keywords

  • Sacroiliac pain
  • Sacroiliac instability
  • Pelvic girdle pain
  • Sacroiliac arthrodesis
  • Arthrodesis
  • Surgery
03

In context

Joint Instability

147 studies on the registry are indexed under Joint Instability; 22 are open to participants now.

This study's enrollment of 9 is below the median of 42 across 80 interventional studies indexed under Joint Instability.

Browse Joint Instability studies →

Lead sponsor

Oslo University Hospital is the lead sponsor of 810 studies on the registry; 148 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Pain in one or more pelvic joints.
  • Minimum 2 positive clinical tests.
  • High pain and disability score
  • Tried adequate physiotherapy without effect.

Exclusion criteria

Exclusion Criteria:

  • Known psychiatric diagnosis
  • Other spine pathology
  • CT verified ankylosis
  • BMI>30
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
9 participants (actual)

Study arms

  • Experimental
    Sacroilliac fusion

    Pastient are treated with sacroiliac joint arthrodesis to the sacroiliac joint and symphysis

    Procedure: Arthrodesis to the sacroiliac joint and symphysis

Interventions

  • ProcedureArthrodesis to the sacroiliac joint and symphysis

    Standard surgical procedures will be used. When the patient has isolated pain in the symphysis isolated fixation will be performed. A 2x2 cm large bone block will be removed and replaced with spongy bone. For fixation the Matta-plate will be applied. To the sacroiliac joint we use an anterior approach. A 2x1,5 cm large bone block will be removed and replaced with spongy bone from the iliac crest. For joint fixation we either use 2 plates or sacroiliac screws. The same procedure will be used on the other side in the cases with bilateral symptoms. Only one side will be operated at a time. After one year it will be decided if it's necessary to perform contralateral surgery.

06

What researchers measure

Primary outcomes

  1. Oswestry Disability Index (ODI)

    Oswestry Disability Index is a 10 item questionnaire comprises 10 questions about physical function. Each item has a 0-5 scale and the raw score is multiplied by 2 and the sum is the total score. Zero represents excellent physical function and 100 is more or less bedridden. This is the most used outcome measure in low back pain studies.

    Time frame: 12 months

  2. Visual Analogue Scale (VAS) 0 to 10

    Visual Analogue Scale is a 0 -10 scale. Zero is no pain and 10 is the worst pain you can imagine. In this study the patients were asked to report the morgning and evening pain by this scale.

    Time frame: 12 months

Secondary outcomes

  1. Healing Measured by CT

    Number of participants with healing as measured by CT data. The outcome was radiological healing vs no signs of radiological healing. In order to be classified as healed the CT scans had to show Clear signs of bone bridging across the sacroiliac joint.

    Time frame: 12 months

07

Results

Posted May 29, 2018

Participant flow

During the study period, from 2007 and 2010, a total of 20 patients with PGP were referred Oslo University Hospital, but only 9 patients met the study's inclusion criteria.

Participant flow — Overall Study
MilestoneSacroliac Joint Fusion
Started9
Completed8
Not completed1
Withdrew: Physician decision1

Outcome measures

PrimaryOswestry Disability Index (ODI)

Oswestry Disability Index is a 10 item questionnaire comprises 10 questions about physical function. Each item has a 0-5 scale and the raw score is multiplied by 2 and the sum is the total score. Zero represents excellent physical function and 100 is more or less bedridden. This is the most used outcome measure in low back pain studies.

Time frame:
12 months
Reported as:
Mean · units on a scale
Oswestry Disability Index (ODI)
units on a scaleSacroliac Joint Fusion
Baseline54 (48 to 60)
One year37 (34 to 40)
PrimaryVisual Analogue Scale (VAS) 0 to 10

Visual Analogue Scale is a 0 -10 scale. Zero is no pain and 10 is the worst pain you can imagine. In this study the patients were asked to report the morgning and evening pain by this scale.

Time frame:
12 months
Reported as:
Mean · units on a scale
Visual Analogue Scale (VAS) 0 to 10
units on a scaleSacroliac Joint Fusion
Baseline81 (76 to 87)
One year57 (49 to 61)
SecondaryHealing Measured by CT

Number of participants with healing as measured by CT data. The outcome was radiological healing vs no signs of radiological healing. In order to be classified as healed the CT scans had to show Clear signs of bone bridging across the sacroiliac joint.

Time frame:
12 months
Reported as:
Count of participants · Participants
Healing Measured by CT
ParticipantsSacroliac Joint Fusion
Healing Measured by CT8

Adverse events

Collected over 1 year. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Sacroliac Joint Fusion0/8 (0%)1/8 (12.5%)3/8 (37.5%)
Most frequent serious events
Most frequent serious events
EventSacroliac Joint Fusion
Nerve damageNervous system disorders1/8
InfectionInfections and infestations1/8
Loss of bladder sensationNervous system disorders1/8
Most frequent other events
Most frequent other events
EventSacroliac Joint Fusion
Transient sensitivity loss to the lateral femoral cutaneous nerveNervous system disorders3/8

Baseline characteristics

Age, Continuous
Age, Continuous(years)Sacroliac Joint Fusion
Median40 (33 to 47)
Sex: Female, Male
Sex: Female, Male(Participants)Sacroliac Joint Fusion
Female9
Male0
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Sacroliac Joint Fusion
American Indian or Alaska Native0
Asian0
Native Hawaiian or Other Pacific Islander0
Black or African American0
White9
More than one race0
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(participants)Sacroliac Joint Fusion
Norway9
Duration of pain
Duration of pain(years)Sacroliac Joint Fusion
Median11 (2 to 25)
BMI
BMI(kg/m2)Sacroliac Joint Fusion
Median25 (20 to 30)
Etiology
Etiology(Participants)Sacroliac Joint Fusion
Post preganancy7
Trauma2
Unilateral/Bilateral
Unilateral/Bilateral(Participants)Sacroliac Joint Fusion
Unilateral pain1
Bilateral pain8
08

Study locations

1 site
  • Oslo university hospital - Ulllevaal
    Oslo, 0407, Norway
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 29, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00900601
Lead sponsor
Oslo University Hospital
Collaborators
Stiftelsen Helse og Rehabilitering
Responsible party
Thomas Johan Kibsgård (Consultant, Oslo University Hospital) — Principal investigator
First posted
May 13, 2009
Start date
Jan 2007
Primary completion
Jun 2011
Completion
Jun 2011
Results posted
May 29, 2018
Last update
May 29, 2018

Study contacts

Thomas J Kibsgaard, PhD student
principal investigator · Oslo university hosptal - Ullevaal

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion